Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Enzalutamide

Enzalutamide

915087-33-1

DISCOVER
Emtricitabine

Emtricitabine

143491-57-0

DISCOVER
16alpha-hydroxy Estrone

16alpha-hydroxy Estrone

566-76-7

DISCOVER
Equol

Equol

94105-90-5

DISCOVER
Erlotinib HCl

Erlotinib HCl

183319-69-9

DISCOVER
ETHOSUXIMIDE CRS (55 MG)

ETHOSUXIMIDE CRS (55 MG)

77-67-8

DISCOVER
ETHYL ACETATE - REFERENCE SPECTRUM (N/A)

ETHYL ACETATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Enalapril Maleate USP

Enalapril Maleate USP

76095-16-4

DISCOVER
1-N-ETHYLGARAMINE SULFATE CRS(60 MG)

1-N-ETHYLGARAMINE SULFATE CRS(60 MG)

NA

DISCOVER
1,1'-ETHYLIDENEBISTRYPTOPHAN CRS (0.002 MG)

1,1'-ETHYLIDENEBISTRYPTOPHAN CRS (0.002 MG)

132685-02-0

DISCOVER
ETHOSUXIMIDE IMPURITY A CRS (30 MG)

ETHOSUXIMIDE IMPURITY A CRS (30 MG)

NA

DISCOVER
Esomeprazole Magnesium USP

Esomeprazole Magnesium USP

217087-09-7

DISCOVER